Aarti Pharmalabs Ltd Share Price (AARTIPHARM)
Check the latest share price of Aarti Pharmalabs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Aarti Pharmalabs Ltd Stock Performance
Get live Aarti Pharmalabs Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹881.5Day's Price Range₹916.9552 Week's Low
52 Week's High
₹551.0552-Week Price Range₹949.5
| Returns % | |
| 1 Month Return | + 9.21 % |
| 3 Month Return | + 14.38 % |
| 1 Year Return | + 46.11 % |
| 3 Year Return | + 207.25 % |
| 5 Year Return | + 207.25 % |
| Market Stats | |
| Previous Close | ₹918.30 |
| Open | ₹910.00 |
| Volume | 2.75L |
| Upper Circuit | ₹1,101.95 |
| Lower Circuit | ₹734.65 |
Aarti Pharmalabs Ltd Fundamentals & Key Indicators
Check Aarti Pharmalabs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹8,027.06 Cr
Return on Equity (ROE)
13.11
PE Ratio (TTM)
29.46
Return on capital employed (ROCE)
16.4
Industry PE ratio
57.39
Beta (LTM)
0.96
P/B Ratio
2.43
Dividend Yield
0.69
PEG Ratio
4.81
Quarterly Earnings Growth YOY
35.39
EPS (TTM)
23.93
Sector
Pharmaceuticals
Book Value
193.88
Technical Analysis
Bullish
View Technical Analysis
How to invest in Aarti Pharmalabs Ltd?
Investing in Aarti Pharmalabs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Aarti Pharmalabs Ltd or AARTIPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Aarti Pharmalabs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Aarti Pharmalabs Ltd with just a few clicks!
Aarti Pharmalabs Ltd Stock's Interest Amongst Investors
Aarti Pharmalabs Ltd Valuation
Track how Aarti Pharmalabs Ltd P/E has moved over time to understand its valuation trends.
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (29.46x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (30.99x)
June 4, 2025
Today’s Price to Earnings Ratio: 29.46x
Aarti Pharmalabs Ltd Financial Results
Get the annual and quarterly financial summary of Aarti Pharmalabs Ltd, including revenue, profit, loss and more.
Indices Featuring Aarti Pharmalabs Ltd Stock
Check stock indices that include Aarti Pharmalabs Ltd.
Aarti Pharmalabs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Aarti Pharmalabs Ltd.
Aarti Pharmalabs Ltd Earnings Results
Aarti Pharmalabs Ltd’s net profit jumped 35.39% since last year same period to ₹88.34Cr in the Q4 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 19.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsAarti Pharmalabs Ltd Dividends February,2025
In the quarter ending December 2024, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.62%.
Read More about Dividends
Aarti Pharmalabs Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aarti Pharmalabs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.29% | 0.00 | |
| Foreign Institutions | 7.36% | 0.00 | |
| Mutual Funds | 0.78% | 0.00 | |
| Retail Investors | 40.81% | 0.00 | |
| Others | 6.76% | 0.00 |
Aarti Pharmalabs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Aarti Pharmalabs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 8,027.06 | 41.45% | 0.57 | 216 | 1,852 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Aarti Pharmalabs Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Aarti Pharmalabs Ltd.
Aarti Pharmalabs Reports Strong Q4 Results - 15 May, 2025
Aarti Pharmalabs reported standalone net sales of Rs 529.62 crore for March 2025, a 27.68% increase year-on-year. Net profit rose 40.98% to Rs 88.85 crore, with EBITDA up 24.42%. EPS increased to Rs 9.80 from Rs 6.95.Aarti Pharmalabs Q4 Profit Up 35.38% - 12 May, 2025
Aarti Pharmalabs reported a 35.38% increase in consolidated net profit to Rs 88.34 crore for Q4 FY25, with revenue rising 11.46% YoY. The company also announced a dividend of Rs 2.5 per share, pending shareholder approval.Aarti Pharmalabs Reports Strong Q3 Growth - 03 May, 2025
Aarti Pharmalabs Limited, a leading manufacturer of APIs and xanthine derivatives, reported a 20% revenue increase to Rs. 542.81 crore and a net profit rise to Rs. 73.99 crore in Q3FY24-25.Aarti Pharmalabs Reports Strong Q3 Growth - 18 Apr, 2025
Aarti Pharmalabs' stock increased by 2.3% to Rs. 733.9, supported by a 20% YoY revenue growth to Rs. 538 crores and a 40% rise in net profit.Aarti Pharmalabs Achieves SBTi Emission Targets Approval - 16 Apr, 2025
Aarti Pharmalabs has received official approval from the Science Based Targets initiative for its emission reduction goals across all scopes, marking a significant commitment to sustainability. This achievement aligns with the Paris Agreement and enhances the company's appeal to environmentally focused partners.
Insights on Aarti Pharmalabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 462.51 Cr → 562.17 Cr (in ₹), with an average increase of 9.1% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, AARTIPHARM stock has moved up by 46.9%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 36.33% to 40.81% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 54.62 Cr → 88.34 Cr (in ₹), with an average increase of 21.2% per quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 8.64% to 7.36% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.93% to 0.78% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 44.66% to 44.29% in Mar 2025 quarter
About Aarti Pharmalabs Ltd
Revenue: ₹563.78Cr as on March 2025 (Q4 FY25)
Net Profit: ₹88.34Cr as on March 2025 (Q4 FY25)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
| Organisation | Aarti Pharmalabs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Rashesh C Gogri |
| E-voting on shares | Click here to vote |
Mutual Funds that own Aarti Pharmalabs Ltd
Check out the Mutual Funds with significant holdings in Aarti Pharmalabs Ltd.
FAQs
What is Aarti Pharmalabs Ltd share price today?
Aarti Pharmalabs Ltd share price today stands at ₹885.65, Open: ₹910, Previous Close: ₹918.3, High: ₹916.95, Low: ₹881.5, 52 Week High: ₹949.5, 52 Week Low: ₹551.05.
What is today's traded volume of Aarti Pharmalabs Ltd?
Today's traded volume of Aarti Pharmalabs Ltd is 2.75L. Which means that 2.75L shares of Aarti Pharmalabs Ltd were bought and sold on the stock market during today's trading session.
What is Aarti Pharmalabs Ltd's market cap today?
Today's market capitalisation of Aarti Pharmalabs Ltd is ₹8,027.06 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Aarti Pharmalabs Ltd?
Aarti Pharmalabs Ltd’s 52 week high is ₹949.5 and 52 week low is ₹551.05. The current share price of Aarti Pharmalabs Ltd is ₹885.65, which is -6.72% down from its 52 week high and 60.72% up from its 52 week low.